Express News | Madrigal Pharmaceuticals Shares up 11%, Akero Therapeutics Gains 6% and Viking Therapeutics Shares Rise 2%
Express News | Shares of Some Liver Disease Drugmakers Rise Between 2% and 11% ; Late-Stage Data From Novo's Weight-Loss Drug Shows Improvement in Fatty Liver Disease
Axonis Therapeutics Announces $115 Million Series A Financing
Akero Therapeutics to Present Data Reinforcing the Efficacy of Efruxifermin at the 75th Annual AASLD The Liver Meeting 2024
Akero Therapeutics, Inc. (AKRO): A Visionary Small-Cap Stock Pick by Hedge Funds
Akero Therapeutics to Present at the H.C. Wainwright 8th Annual MASH Virtual Conference
